Russian Court Cases - Update

Summary by AI ^BETAClose X

JPMorgan Emerging EMEA Securities announced an update regarding lawsuits filed by VTB Bank and Sberbank in Russia. The proceedings before the Court of Cassation concerning VTB Bank's $439.5 million claim have been suspended, as the court will await the outcome of separate claims involving J.P. Morgan legal entities at the Supreme Court. The company previously disclosed claims totaling $439.5 million, $81.3 million, $74.5 million, and €108 million from VTB Bank, and $830,183 from Sberbank.

Disclaimer*

JPMorgan Emerging EMEA Securities

28 April 2026

LONDON STOCK EXCHANGE ANNOUNCEMENT

JPMORGAN EMERGING EUROPE, MIDDLE EAST & AFRICA SECURITIES PLC

('the Company' or 'JEMA')

Legal Entity Identifier: 549300II3MHI98ZLVH37

Russian Court Cases - Update

Further to the Board's previous RNS announcements regarding the lawsuits filed by VTB Bank in Russia claiming $439.5m, $81.3 million, $74.5 million and €108 million and the lawsuit filed by Sberbank in Russia claiming $830,183 against eight J.P. Morgan legal entities and the Company, the Board announces the following update from JPMorgan Funds Limited (the Company's Manager) in respect of the VTB $439.5m claim (in italics):

"Further to the announcement on 13th April 2026, the proceedings before the Court of Cassation in respect of the appeal filed in the VTB $439.5m claim have been suspended.

The Court of Cassation has indicated that it does not intend to schedule a further hearing until the appeals filed by the relevant J.P. Morgan legal entities to the Supreme Court in a separate claim unrelated to the Company have been considered."

The Board will provide further updates as the cases progress.

28th April 2026

For further information:

Joel Clopon, Neil Martin, JPMorgan Funds Limited 0800 20 40 20

Hugh Jonathan, Deutsche Numis 020 7260 1000

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END